Mechanism research found that formononetin may ameliorate hyperglycemia-induced neuropathic condition in T2DM rats by activating sirtuin1(SIRT1) and nerve growth factor (NGF) pathway in sciatic nerve tissue (Oza and Kulkarni, 2020). Here, NGF is linked to type 2 diabetes mellitus.